Last update 31 Oct 2025

HLA-DQ2-targeting compounds(Immunomolecular Therapeutics)

Overview

Basic Info

Drug Type
Chemical drugs
Synonyms-
Target
HLA
Action
modulators
Mechanism
HLA modulators(Human leukocyte antigen modulators)
Therapeutic Areas
NeoplasmsImmune System DiseasesNervous System Diseases+ [3]
Active Indication
Addison DiseaseCeliac DiseaseDiabetes Mellitus, Type 1+ [1]
Inactive Indication-
Originator Organization
Aurimi Therapeutics, Inc.Aurimi Therapeutics, Inc.
Active Organization
Aurimi Therapeutics, Inc.Aurimi Therapeutics, Inc.
Inactive Organization-
License Organization-
Drug Highest PhasePreclinical
First Approval Date-
Regulation-

Related

100 Clinical Results associated with HLA-DQ2-targeting compounds(Immunomolecular Therapeutics)
Login to view more data
100 Translational Medicine associated with HLA-DQ2-targeting compounds(Immunomolecular Therapeutics)
Login to view more data
100 Patents (Medical) associated with HLA-DQ2-targeting compounds(Immunomolecular Therapeutics)
Login to view more data
100 Deals associated with HLA-DQ2-targeting compounds(Immunomolecular Therapeutics)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Addison DiseasePreclinical
United States
Aurimi Therapeutics, Inc.Aurimi Therapeutics, Inc.
07 Feb 2023
Celiac DiseasePreclinical
United States
Aurimi Therapeutics, Inc.Aurimi Therapeutics, Inc.
07 Feb 2023
Diabetes Mellitus, Type 1Preclinical
United States
Aurimi Therapeutics, Inc.Aurimi Therapeutics, Inc.
07 Feb 2023
Myasthenia GravisPreclinical
United States
Aurimi Therapeutics, Inc.Aurimi Therapeutics, Inc.
07 Feb 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free